By interrupting their interaction, were effectively collapsing the structural foundation that allows fibrosis to progress. Unlike traditional therapies that attempt to inhibit FAKs enzymatic activity often with poor specificity and side effects FN-2012 works by disrupting protein-protein binding
Liz graduated from Pepperdine University with a degree in Biology in 1994
The phosphocholine head group in phospholipids of normal healthy cell membranes is not accessible but, when cells are damaged and die, enhanced availability of lysophosphatidylcholine and disruption of the lipid bilayer expose phosphocholine residues to which CRP avidly binds ( In acute respiratory distress syndrome (ARDS), there is extensive overproduction of free radicals and reduced extracellular and intracellular GSH leading to oxidative cell damage ( Glutathione is an important antioxidant in the lungs, but its concentration is low in the airways of patients with cystic fibrosis, since GSH is transported into the airways by the cystic fibrosis transmembrane conductance regulator, which is mutated in cystic fibrosis patients (123), and then, the use of precursors of GSH synthesis like NAC and cystine could be more effective in the synthesis of GSH (124)

For other vial strengths the principle is the same aim for a 1 mg/ml final concentration so the math at the syringe stays straightforward
Enhanced angiogenesis is a key feature of the Wolverine Stack in combined pre-clinical studies